Menu Search
Equities

Dr Miele Cosmed Group SA

DMG:WSE

Dr Miele Cosmed Group SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (PLN)5.10
  • Today's Change-0.14 / -2.67%
  • Shares traded18.48k
  • 1 Year change+47.40%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in PLNIncome statement in PLNView more

Year on year Dr Miele Cosmed Group SA grew revenues 12.08% from 396.57m to 444.48m while net income improved from a loss of 2.27m to a gain of 22.22m.
Gross margin43.02%
Net profit margin7.44%
Operating margin10.35%
Return on assets9.01%
Return on equity14.87%
Return on investment13.29%
More ▼

Cash flow in PLNView more

In 2023, Dr Miele Cosmed Group SA increased its cash reserves by 52.27%, or 4.91m. The company earned 31.25m from its operations for a Cash Flow Margin of 7.03%. In addition the company used 12.90m on investing activities and also paid 13.45m in financing cash flows.
Cash flow per share0.5506
Price/Cash flow per share9.26
Book value per share2.92
Tangible book value per share1.51
More ▼

Balance sheet in PLNView more

Dr Miele Cosmed Group SA has a Debt to Total Capital ratio of 20.96%, a higher figure than the previous year's 8.41%.
Current ratio1.07
Quick ratio0.6347
Total debt/total equity0.2652
Total debt/total capital0.2096
More ▼

Growth rates in PLN

Year on year, growth in earnings per share excluding extraordinary items increased 1,080.80%.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)14.58%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		238.10
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.